Clinical Lung Cancer

Published by: Elsevier Inc.  

People

  1. Paik
    Paik
  2. Wu
    Wu
  3. Kris
    Kris
  4. Riely
    Riely
  5. Zhang
    Zhang
  6. Chaft
    Chaft
  7. Rekhtman
    Rekhtman
  8. Rudin
    Rudin
  9. Yu
    Yu
  10. Chang
    Chang

Groups

  1. Department of Medicine (25)
  2. Solid Tumor Oncology Division (25)
  3. Thoracic Oncology (21)
  4. Department of Pathology and Laboratory Medicine (7)
  5. Radiology, Department of (7)
  6. Radiation Oncology, Department of (6)
  7. Surgery (5)
  8. Biostatistics Service (4)
  9. Epidemiology and Biostatistics (4)
  10. GSK Faculty (4)
Search Within
Formats
  1. Journal Article (37)
  2. Review (2)
  3. Editorial (1)
Groups
  1. Department of Medicine (25)
  2. Solid Tumor Oncology Division (25)
  3. Thoracic Oncology (21)
  4. Department of Pathology and Laboratory Medicine (7)
  5. Radiology, Department of (7)
  6. Radiation Oncology, Department of (6)

More Groups

People
  1. Andreas Rimner (6)
  2. Paul Paik (6)
  3. Abraham Wu (5)
  4. Jamie Chaft (5)
  5. Amanda Foster (4)
  6. Gregory Riely (4)

More People

Years
  1. 2025 (3)
  2. 2024 (2)
  3. 2023 (2)
  4. 2022 (4)
  5. 2021 (3)
  6. 2020 (3)

More Years

Publishers
  1. Elsevier Inc. (40)

Results (40)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Neratinib efficacy in patients with EGFR exon 18-mutant non-small-cell lung cancer: Findings from the SUMMIT basket trial
    Journal Article

    Goldman, J. W.; Bueno, A. M.; Dooms, C.; Jhaveri, K.; de Miguel, M.; Piha-Paul, S. A.; Unni, N.; Zick, A.; Mahipal, A.; Suga, J. M.; more...
    Clinical Lung Cancer (2025)

    Fulltext@MSK | Save
  • Phase II parallel arm study of sacituzumab govitecan-hziy in patients with advanced thymoma or thymic carcinoma
    Journal Article

    Marks, J. A.; Ahn, J.; Reuss, J. E.; Barbie, D.; Altan, M.; Gutierrez, M. E.; Garassino, M. C.; Riely, G. J.; Wakelee, H.; Liu, S. V.; more...
    Clinical Lung Cancer (2025)

    Fulltext@MSK | Save
  • Transarterial embolization for the management of emergent hemoptysis in patients with primary and metastatic lung tumors
    Journal Article

    Geevarghese, R.; Petre, E. N.; Ziv, E.; Santos, E.; Rodriguez, L.; Zhao, K.; Sotirchos, V. S.; Solomon, S. B.; Alexander, E. S.
    Clinical Lung Cancer (2025)

    Fulltext@MSK | Save
  • Brief report: Updated efficacy and safety data from an integrated analysis of entrectinib in locally advanced/metastatic ROS1 fusion-positive non–small-cell lung cancer
    Journal Article

    Fan, Y.; Drilon, A.; Chiu, C. H.; Loong, H. H. F.; Siena, S.; Krzakowski, M.; Dziadziuszko, R.; Zeuner, H.; Xue, C.; Krebs, M. G.
    Clinical Lung Cancer (2024)

    Fulltext@MSK | Save
  • A brief report on the patterns of mediastinal nodal failure in resectable stage IB-IIIA NSCLC treated with neoadjuvant immunotherapy combinations, a secondary analysis of a prospective trial
    Journal Article

    Mao, S.; Rosner, S.; Forde, P. M.; Chaft, J. E.; Jones, D. R.; Spicer, J.; Hales, R. K.; Ha, J. S.; Hu, C.; Voong, K. R.
    Clinical Lung Cancer (2024)

    Fulltext@MSK | Save
  • Comparison of stage I non–small-cell lung cancer treatments for patients living with HIV: A simulation study
    Journal Article

    Sigel, K.; Silverberg, M. J.; Crothers, K.; Park, L.; Lishchenko, I.; Han, X.; Leyden, W.; Kale, M.; Stone, K.; Sigel, C.; more...
    Clinical Lung Cancer (2023)

    Fulltext@MSK | Save
  • Short report of a phase ii trial of nintedanib in recurrent malignant pleural mesothelioma (MPM)
    Journal Article

    Wozniak, A. J.; Schneider, B.; Kalemkerian, G. P.; Daly, B.; Chen, W.; Ventimiglia, J.; Nagasaka, M.; Zauderer, M. G.
    Clinical Lung Cancer (2023)

    Fulltext@MSK | Save
  • Survival outcomes and treatment patterns in patients with NFE2L2 and/or KEAP1 mutation-positive advanced squamous cell NSCLC using a real-world clinico-genomic database
    Journal Article

    Wu, Y.; Yin, Y.; Crossland, V.; Vincent, S.; Paik, P. K.; Lineberry, N.; Faller, D. V.
    Clinical Lung Cancer (2022)

    Fulltext@MSK | Save
  • Safety of tepotinib in patients with MET exon 14 skipping NSCLC and recommendations for management
    Journal Article

    Veillon, R.; Sakai, H.; Le, X.; Felip, E.; Cortot, A. B.; Smit, E. F.; Park, K.; Griesinger, F.; Britschgi, C.; Wu, Y. L.; more...
    Clinical Lung Cancer (2022)

    Fulltext@MSK | Save
  • Rationale and design of the phase 3 KEYLYNK-013 study of pembrolizumab with concurrent chemoradiotherapy followed by pembrolizumab with or without olaparib for limited-stage small-cell lung cancer
    Journal Article

    Rimner, A.; Lai, W. C. V.; Califano, R.; Jabbour, S. K.; Rudin, C. M.; Faivre-Finn, C.; Cho, B. C.; Kato, T.; Yu, J.; Chafin, W.; more...
    Clinical Lung Cancer (2022)

    Fulltext@MSK | Save

    • Clinical Lung Cancer – authorized name for:

    Name ISSN / ISBN Publisher
    Clinical Lung Cancer 1525-7304 Elsevier Inc.
    Clinical Lung Cancer 1938-0690 Elsevier Inc.
    Clinical Lung Cancer 15257304 The Authors
    Clinical Lung Cancer 15257304 Unknown
    Clinical Lung Cancer 1525-7304 Elsevier Inc.
    Clinical Lung Cancer 15257304 2022
    Clinical Lung Cancer 1525-7304 Elsevier Inc.
    Clinical Lung Cancer 15257304 2023
    Clinical Lung Cancer 1525-7304 Cig Media Group, Lp
    Clinical Lung Cancer 1525-7304 Unknown
    Clinical Lung Cancer 15257304 2024
    Clinical Lung Cancer 15257304 Elsevier Inc.
    Clinical lung cancer 19380690 Unknown
    Clinical Lung Cancer 1525-7304 Elsevier Inc.
    Clinical Lung Cancer 0284-186X Unknown